News Conference News ISC 2019 Durability of Surgery, Stenting for Symptomatic Carotid Stenosis Good for Up to a Decade Todd Neale February 11, 2019
News Conference News ISC 2019 MISTIE III Misses Primary Endpoint, but Stroke Experts See Encouraging Results Todd Neale February 08, 2019
News Conference News ISC 2019 Mechanical Thrombectomy Outcomes May Be Worse at Low-Volume Stroke Centers Todd Neale February 07, 2019
News Conference News ISC 2019 Off-Label Underdosing of DOACs Tied to Worse Outcomes in A-fib Patients Todd Neale February 07, 2019
News Conference News STS 2019 Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015 Yael L. Maxwell February 06, 2019
News Conference News ISC 2019 Opioid Epidemic Brings Higher Rates of Endocarditis, Stroke Todd Neale February 06, 2019
News Conference News ISET 2019 Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting Caitlin E. Cox January 31, 2019
News Conference News STS 2019 Past SAVR Outcomes Matter More Than Volume in Determining Future Performance Yael L. Maxwell January 31, 2019
News Conference News ISET 2019 PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research Caitlin E. Cox January 28, 2019
News Conference News WCC 2018 Is It Time to Loosen Restrictions on Saturated Fats and Salt? Todd Neale December 14, 2018
News Conference News WCC 2018 Man’s Best Friend, Especially After an MI or Stroke Todd Neale December 11, 2018
News Conference News WCC 2018 True Resistant Hypertension Is Prevalent Worldwide Todd Neale December 07, 2018
News Conference News WCC 2018 WHF Celebrates 40th Anniversary as World Congress Kicks Off in Dubai Todd Neale December 05, 2018
News Conference News AHA 2018 Complications Following TAVR Are Going Down, US Data Show Yael L. Maxwell November 20, 2018
News Conference News AHA 2018 EWTOPIA 75: Ezetimibe Bests Dietary Counseling Alone in Lowering Cardiovascular Risk for Elderly Japanese Patients Yael L. Maxwell November 16, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News AHA 2018 Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI Michael O'Riordan November 14, 2018
News Conference News AHA 2018 TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG Shelley Wood November 13, 2018
News Conference News AHA 2018 Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF Todd Neale November 11, 2018